ArticleScience advances2026
GenAI-Net: A generative AI framework for automated biomolecular network design.
Article in Science advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Biomolecular networks underlie both natural biological processes and engineered cellular technologies, from intracellular regulation and ecological dynamics to biomanufacturing, smart therapeutics, and cell-based diagnostics. However, designing chemical reaction networks (CRNs) that implement a desired dynamical function remains a challenging task. Although candidate networks can be evaluated by simulation, the inverse problem of discovering networks from behavioral specifications remains difficult. It requires navigating vast spaces of topologies and kinetic parameters governed by nonlinear and potentially stochastic dynamics. Here, we introduce GenAI-Net, a generative artificial intelligence framework that automates CRN design by coupling reaction proposal to simulation-based evaluation defined by a user-specified objective. GenAI-Net efficiently produces topologically diverse solutions across design tasks, including dose-response shaping, complex logic gates, classifiers, oscillators, habituation, robust perfect adaptation, and noise reduction in stochastic settings. By turning specifications into families of circuit candidates, GenAI-Net provides a route to programmable biomolecular circuit design and accelerates translation from desired function to implementable mechanisms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.